Literature DB >> 18990306

Diabetic nephropathy in American Indians, with a special emphasis on the Pima Indians.

Meda E Pavkov1, William C Knowler, Robert L Hanson, Robert G Nelson.   

Abstract

Diabetes affects American Indians disproportionately compared with other racial/ethnic groups in the United States and is almost exclusively type 2 diabetes. Much of our knowledge about diabetes in American Indians comes from studies in a few tribes. The most extensively studied American Indians are the Pima Indians from the Gila River Indian Community in Arizona, who participated in a longitudinal study of diabetes and its complications between 1965 and 2007. They have one of the highest reported incidence and prevalence of type 2 diabetes in the world, and kidney disease attributable to diabetes is a major cause of morbidity and mortality. In this article, we examine the course, determinants, and trends of diabetic kidney disease in American Indians, with special emphasis on studies conducted in the Pima Indians. We also review therapeutic strategies for managing diabetic kidney disease.

Entities:  

Mesh:

Year:  2008        PMID: 18990306      PMCID: PMC3480511          DOI: 10.1007/s11892-008-0083-1

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  49 in total

1.  A worldwide survey of haplotype variation and linkage disequilibrium in the human genome.

Authors:  Donald F Conrad; Mattias Jakobsson; Graham Coop; Xiaoquan Wen; Jeffrey D Wall; Noah A Rosenberg; Jonathan K Pritchard
Journal:  Nat Genet       Date:  2006-10-22       Impact factor: 38.330

2.  Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes.

Authors:  Wendy A Shultis; E Jennifer Weil; Helen C Looker; Jeffrey M Curtis; Marc Shlossman; Robert J Genco; William C Knowler; Robert G Nelson
Journal:  Diabetes Care       Date:  2007-02       Impact factor: 19.112

3.  Kidney disease among the Zuni Indians: the Zuni Kidney Project.

Authors:  Marina Scavini; Vallabh O Shah; Christine A Stidley; Francesca Tentori; Susan S Paine; Antonia M Harford; Andrew S Narva; David S Kessler; Arlene Bobelu; Carleton P Albert; Jeanette Bobelu; Eunice Jamon; Kathy Natachu; Donica Neha; Thomas K Welty; Jean W MacCluer; Philip G Zager
Journal:  Kidney Int Suppl       Date:  2005-08       Impact factor: 10.545

Review 4.  Low birth weight, nephron number, and kidney disease.

Authors:  Valerie A Luyckx; Barry M Brenner
Journal:  Kidney Int Suppl       Date:  2005-08       Impact factor: 10.545

5.  Albuminuria within the "normal" range and risk of cardiovascular disease and death in American Indians: the Strong Heart Study.

Authors:  Jiaqiong Xu; William C Knowler; Richard B Devereux; Jeunliang Yeh; Jason G Umans; Momotaz Begum; Richard R Fabsitz; Elisa T Lee
Journal:  Am J Kidney Dis       Date:  2007-02       Impact factor: 8.860

6.  Increasing incidence of proteinuria and declining incidence of end-stage renal disease in diabetic Pima Indians.

Authors:  M E Pavkov; W C Knowler; P H Bennett; H C Looker; J Krakoff; R G Nelson
Journal:  Kidney Int       Date:  2006-09-27       Impact factor: 10.612

7.  Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians.

Authors:  Meda E Pavkov; Peter H Bennett; William C Knowler; Jonathan Krakoff; Maurice L Sievers; Robert G Nelson
Journal:  JAMA       Date:  2006-07-26       Impact factor: 56.272

8.  Predominant effect of kidney disease on mortality in Pima Indians with or without type 2 diabetes.

Authors:  Meda E Pavkov; Peter H Bennett; Maurice L Sievers; Jonathan Krakoff; Desmond E Williams; William C Knowler; Robert G Nelson
Journal:  Kidney Int       Date:  2005-09       Impact factor: 10.612

9.  Predictive power of sequential measures of albuminuria for progression to ESRD or death in Pima Indians with type 2 diabetes.

Authors:  Meda E Pavkov; William C Knowler; Robert L Hanson; Peter H Bennett; Robert G Nelson
Journal:  Am J Kidney Dis       Date:  2008-03-20       Impact factor: 8.860

10.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

View more
  9 in total

1.  Knowledge, attitudes, and beliefs that can influence infant feeding practices in American Indian mothers.

Authors:  Cara L Eckhardt; Tam Lutz; Njeri Karanja; Jared B Jobe; Gerardo Maupomé; Cheryl Ritenbaugh
Journal:  J Acad Nutr Diet       Date:  2014-06-18       Impact factor: 4.910

Review 2.  Renal biopsy-driven molecular target identification in glomerular disease.

Authors:  Maja T Lindenmeyer; Matthias Kretzler
Journal:  Pflugers Arch       Date:  2017-06-29       Impact factor: 3.657

3.  Increased lipogenesis and impaired β-oxidation predict type 2 diabetic kidney disease progression in American Indians.

Authors:  Farsad Afshinnia; Viji Nair; Jiahe Lin; Thekkelnaycke M Rajendiran; Tanu Soni; Jaeman Byun; Kumar Sharma; Patrice E Fort; Thomas W Gardner; Helen C Looker; Robert G Nelson; Frank C Brosius; Eva L Feldman; George Michailidis; Matthias Kretzler; Subramaniam Pennathur
Journal:  JCI Insight       Date:  2019-11-01

4.  Differential mortality and the excess burden of end-stage renal disease among First Nations people with diabetes mellitus: a competing-risks analysis.

Authors:  Ying Jiang; Nathaniel Osgood; Hyun-Ja Lim; Mary Rose Stang; Roland Dyck
Journal:  CMAJ       Date:  2013-12-02       Impact factor: 8.262

5.  Structural Predictors of Loss of Renal Function in American Indians with Type 2 Diabetes.

Authors:  Gudeta D Fufaa; E Jennifer Weil; Kevin V Lemley; William C Knowler; Frank C Brosius; Berne Yee; Michael Mauer; Robert G Nelson
Journal:  Clin J Am Soc Nephrol       Date:  2016-01-20       Impact factor: 8.237

6.  Vital Signs: Decrease in Incidence of Diabetes-Related End-Stage Renal Disease among American Indians/Alaska Natives - United States, 1996-2013.

Authors:  Ann Bullock; Nilka Ríos Burrows; Andrew S Narva; Karen Sheff; Israel Hora; Akaki Lekiachvili; Hannah Cain; David Espey
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-01-13       Impact factor: 17.586

7.  Association of the HLA-DQA1 and HLA-DQB1 Alleles in Type 2 Diabetes Mellitus and Diabetic Nephropathy in the Han Ethnicity of China.

Authors:  Ze-Jun Ma; Pei Sun; Gang Guo; Rui Zhang; Li-Ming Chen
Journal:  J Diabetes Res       Date:  2013-02-26       Impact factor: 4.011

8.  Does losartan prevent progression of early diabetic nephropathy in American Indians with type 2 diabetes?

Authors:  Susanne B Nicholas; Sudha K Iyengar
Journal:  Diabetes       Date:  2013-09       Impact factor: 9.461

9.  Transforming growth factor-β-induced cross talk between p53 and a microRNA in the pathogenesis of diabetic nephropathy.

Authors:  Supriya D Deshpande; Sumanth Putta; Mei Wang; Jennifer Y Lai; Markus Bitzer; Robert G Nelson; Linda L Lanting; Mitsuo Kato; Rama Natarajan
Journal:  Diabetes       Date:  2013-05-06       Impact factor: 9.461

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.